Literature DB >> 2159240

Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.

T Voisin1, C Rouyer-Fessard, M Laburthe.   

Abstract

Rat small intestinal epithelium is equipped with peptide YY (PYY)-preferring receptors, which also recognize neuropeptide Y (NPY) with high affinity. We therefore examined the distribution of PYY-NPY receptors along the villus-crypt axis after separation of mature villus cells from proliferative crypt cells. Specific 125I-labeled PYY binding was nine times higher in crypt cells than in villus cells. This was not due to differential degradation of PYY or PYY binding sites by the two cell populations. Rather, Scatchard analysis of equilibrium binding data showed that binding capacity (Bmax) of receptors increased from villus to crypt. Bmax were 166 +/- 36 and 21 +/- 3 fmol/mg protein, and dissociation constants (Kd) were 0.10 +/- 0.02 and 0.05 +/- 0.02 nM in crude membranes prepared from crypt and villus cells, respectively. For all cell populations, NPY and rat pancreatic polypeptide were 8- and 1,800-fold less potent than PYY in inhibiting 125I-PYY binding, respectively. Therefore, receptors appear to be PYY preferring along the entire villus-crypt axis. Both peptides (at the maximally active concentration of 1 microM) reduced vasoactive intestinal peptide (VIP)-stimulated adenosine 3',5'-cyclic monophosphate (cAMP) by 50% in crypt cells. PYY was four to six times more potent than NPY in agreement with the expression of a PYY-preferring receptor. By contrast, neither PYY nor NPY altered VIP-stimulated cAMP levels in villus cells. These results indicate that PYY-preferring receptors, negatively coupled to the cAMP production system, are preferentially expressed in crypt cells where intestinal ionic secretion is believed to take place.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159240     DOI: 10.1152/ajpgi.1990.258.5.G753

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Na-K-2Cl cotransporter gene expression and function during enterocyte differentiation. Modulation of Cl- secretory capacity by butyrate.

Authors:  J B Matthews; I Hassan; S Meng; S Y Archer; B J Hrnjez; R A Hodin
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

2.  Cellular localization of the class I alcohol dehydrogenase transcript in adult rat tissues.

Authors:  T G Tietjen; C H Mjaatvedt; V W Yang
Journal:  Histochem J       Date:  1994-06

3.  Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Authors:  Kayla D Newman; Thaer R Mhalhal; Martha C Washington; John C Heath; Ayman I Sayegh
Journal:  Dig Dis Sci       Date:  2017-10-13       Impact factor: 3.199

4.  The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.

Authors:  A Couvineau; J J Maoret; C Rouyer-Fessard; I Carrero; M Laburthe
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

5.  Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).

Authors:  Catriona M H Anderson; Maria E Mendoza; David J Kennedy; Demetrio Raldua; David T Thwaites
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Opioid receptors on guinea-pig intestinal crypt epithelial cells.

Authors:  M E Lang; J S Davison; S L Bates; J B Meddings
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

7.  Multiple G-protein-dependent pathways mediate the antisecretory effects of somatostatin and clonidine in the HT29-19A colonic cell line.

Authors:  G Warhurst; L A Turnberg; N B Higgs; A Tonge; J Grundy; K E Fogg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine.

Authors:  M Buyse; F Berlioz; S Guilmeau; A Tsocas; T Voisin; G Péranzi; D Merlin; M Laburthe; M J Lewin; C Rozé; A Bado
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.